Keith A. Goldan - Net Worth and Insider Trading

Keith A. Goldan Net Worth

The estimated net worth of Keith A. Goldan is at least $1 Million dollars as of 2024-11-05. Keith A. Goldan is the CFO of Syndax Pharmaceuticals Inc and owns about 52,623 shares of Syndax Pharmaceuticals Inc (SNDX) stock worth over $991,944. Keith A. Goldan is the CFO of OptiNose Inc and owns about 90,193 shares of OptiNose Inc (OPTN) stock worth over $61,340. Keith A. Goldan is also the SVP and CFO of Fibrocell Science Inc and owns about 133 shares of Fibrocell Science Inc (FCSC) stock worth over $399. Details can be seen in Keith A. Goldan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Keith A. Goldan has not made any transactions after 2024-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Keith A. Goldan

To

Keith A. Goldan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Keith A. Goldan owns 3 companies in total, including OptiNose Inc (OPTN) , Fibrocell Science Inc (FCSC) , and Syndax Pharmaceuticals Inc (SNDX) .

Click here to see the complete history of Keith A. Goldan’s form 4 insider trades.

Insider Ownership Summary of Keith A. Goldan

Ticker Comapny Transaction Date Type of Owner
OPTN OptiNose Inc 2021-09-16 Chief Financial Officer
FCSC Fibrocell Science Inc 2016-03-01 SVP and CFO
SNDX Syndax Pharmaceuticals Inc 2024-06-14 Chief Financial Officer

Keith A. Goldan Latest Holdings Summary

Keith A. Goldan currently owns a total of 3 stocks. Among these stocks, Keith A. Goldan owns 52,623 shares of Syndax Pharmaceuticals Inc (SNDX) as of June 14, 2024, with a value of $991,944 and a weighting of 94.14%. Keith A. Goldan owns 90,193 shares of OptiNose Inc (OPTN) as of September 16, 2021, with a value of $61,340 and a weighting of 5.82%. Keith A. Goldan also owns 133 shares of Fibrocell Science Inc (FCSC) as of August 11, 2015, with a value of $399 and a weighting of 0.04%.

Latest Holdings of Keith A. Goldan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SNDX Syndax Pharmaceuticals Inc 2024-06-14 52,623 18.85 991,944
OPTN OptiNose Inc 2021-09-16 90,193 0.68 61,340
FCSC Fibrocell Science Inc 2015-08-11 133 3.00 399

Holding Weightings of Keith A. Goldan


Keith A. Goldan Form 4 Trading Tracker

According to the SEC Form 4 filings, Keith A. Goldan has made a total of 2 transactions in Syndax Pharmaceuticals Inc (SNDX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Syndax Pharmaceuticals Inc is the acquisition of 1,250 shares on June 14, 2024, which cost Keith A. Goldan around $25,038.

According to the SEC Form 4 filings, Keith A. Goldan has made a total of 4 transactions in OptiNose Inc (OPTN) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in OptiNose Inc is the sale of 578 shares on September 16, 2021, which brought Keith A. Goldan around $1,613.

According to the SEC Form 4 filings, Keith A. Goldan has made a total of 0 transactions in Fibrocell Science Inc (FCSC) over the past 5 years. The most-recent trade in Fibrocell Science Inc is the acquisition of 133 shares on August 11, 2015, which cost Keith A. Goldan around $12,660.

Insider Trading History of Keith A. Goldan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Keith A. Goldan Trading Performance

GuruFocus tracks the stock performance after each of Keith A. Goldan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Keith A. Goldan is -5.81%. GuruFocus also compares Keith A. Goldan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Keith A. Goldan within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Keith A. Goldan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Keith A. Goldan

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.16 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 1.65 LIMIT LIMIT LIMIT LIMIT LIMIT

Keith A. Goldan Ownership Network

Ownership Network List of Keith A. Goldan

No Data

Ownership Network Relation of Keith A. Goldan

Insider Network Chart

Keith A. Goldan Owned Company Details

What does OptiNose Inc do?

Who are the key executives at OptiNose Inc?

Keith A. Goldan is the Chief Financial Officer of OptiNose Inc. Other key executives at OptiNose Inc include Chief Legal Officer & Corp Sec Marino Michael F Iii , President & COO Ramy A Mahmoud , and Chief Accounting Officer Anthony J Krick .

OptiNose Inc (OPTN) Insider Trades Summary

Over the past 18 months, Keith A. Goldan made no insider transaction in OptiNose Inc (OPTN). Other recent insider transactions involving OptiNose Inc (OPTN) include a net sale of 229,564 shares made by Ramy A Mahmoud , a net sale of 83,902 shares made by Marino Michael F Iii , and a net sale of 9,814 shares made by Anthony J Krick .

In summary, during the past 3 months, insiders sold 8,107 shares of OptiNose Inc (OPTN) in total and bought 0 shares, with a net sale of 8,107 shares. During the past 18 months, 323,280 shares of OptiNose Inc (OPTN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 323,280 shares.

OptiNose Inc (OPTN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

OptiNose Inc Insider Transactions

No Available Data

Keith A. Goldan Mailing Address

Above is the net worth, insider trading, and ownership report for Keith A. Goldan. You might contact Keith A. Goldan via mailing address: 227 Washington Street, Suite 200, Conshohocken Pa 19428.